CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleRevenue is $859.81M, above the global median of $520.53M
- FinancialsAltman Z-Score 1.34: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.78%Below 5Y avg (0.78%)
Annual Rate
CNY 0.07Paid unknown
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.11BCNY908.06M · vs all stocks (USD)
Trailing P/E
15.83xvs Medical Instruments & Supplies peers
Revenue (TTM)
5.79BCNY859.81M · vs all stocks (USD)
Profit Margin
5.72%vs Medical Instruments & Supplies peers
Beta
0.6320xvs all stocks
52-Week Change
-2.84%vs all stocks
Forward Annual Dividend Yield
0.78%vs all stocks
Market Capitalization
6.11BCNY908.06M · vs all stocks (USD)
Enterprise Value
5.54BCNY822.97M · vs all stocks (USD)
Trailing P/E
15.83xvs Medical Instruments & Supplies peers
Forward P/E
21.92xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.06xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.10xvs Medical Instruments & Supplies peers
Enterprise to Revenue
0.9570xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
10.43xvs Medical Instruments & Supplies peers
Gross Margin
37.55%vs Medical Instruments & Supplies peers
Profit Margin
5.72%vs Medical Instruments & Supplies peers
Operating Margin
6.15%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.32%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
6.57%vs Medical Instruments & Supplies peers
Revenue (TTM)
5.79BCNY859.81M · vs all stocks (USD)
Revenue per Share (TTM)
9.19CNYUpdated Aug 19, 2026Quarterly Revenue Growth
2.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.92BCNY284.48M · vs all stocks (USD)
EBITDA (TTM)
339.02MCNY50.35M · vs all stocks (USD)
Net Income (TTM)
331.01MCNY49.16M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-33.12%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
796.27MCNY118.26M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
102.14MCNY15.17M · vs all stocks (USD)
Forward Annual Dividend Rate
0.0700CNYUpdated Aug 19, 2026Forward Annual Dividend Yield
0.78%vs all stocks
Trailing Annual Dividend Rate
0.0700CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.78%vs all stocks
5-Year Average Dividend Yield
0.78%vs all stocks
Payout Ratio
0.00%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
21.49MCNYFY2025 · Dec 31, 2025Revenue
5.76BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.91BCNYFY2025 · Dec 31, 2025Gross Profit
1.86BCNYFY2025 · Dec 31, 2025Operating Income
410.86MCNY61.02M · vs all stocks (USD)
Pre-tax Income
247.58MCNYFY2025 · Dec 31, 2025Income Tax Expense
-1.13MCNYFY2025 · Dec 31, 2025Net Income
248.70MCNYFY2025 · Dec 31, 2025EBIT
318.36MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
689.48MCNYFY2025 · Dec 31, 2025Research & Development
484.80MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
330.39MCNYFY2025 · Dec 31, 2025Other Operating Expenses
99.59MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
11.15MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
70.78MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4265CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4265CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
597.07MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
597.07MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
248.70MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
5.95MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
810.99MCNYFY2025 · Dec 31, 2025Free Cash Flow
597.85MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.18BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
248.70MCNYFY2025 · Dec 31, 2025Other Non-cash Items
71.70MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
107.05MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
383.53MCNYFY2025 · Dec 31, 2025Capital Expenditures
-213.14MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.57BCNYFY2025 · Dec 31, 2025Sale of Investments
4.32BCNYFY2025 · Dec 31, 2025Other Investing Activity
-7.09MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-461.71MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.47BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.48BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-49.60MCNYFY2025 · Dec 31, 2025Other Financing Charges
-45.48MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-107.61MCNYFY2025 · Dec 31, 2025Shares Outstanding
715.09MSharesUpdated Aug 19, 2026Float Shares
474.67MSharesUpdated Aug 19, 2026% Held by Insiders
33.71%vs all stocks
% Held by Institutions
7.57%vs all stocks
Total Cash (MRQ)
2.12BCNY314.76M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.96CNYUpdated Aug 19, 2026Total Debt (MRQ)
1.53BCNY226.98M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2735xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.27xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
7.79CNYUpdated Aug 19, 2026Total Assets
13.16BCNY1.95B · vs all stocks (USD)
Total Current Assets
8.15BCNYFY2025 · Dec 31, 2025Total Liabilities
7.59BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.01BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.09BCNYFY2025 · Dec 31, 2025Total Current Liabilities
6.49BCNYFY2025 · Dec 31, 2025Cash
1.18BCNYFY2025 · Dec 31, 2025Cash Equivalents
335.76MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.52BCNYFY2025 · Dec 31, 2025Other Short-term Investments
744.51MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.55BCNYFY2025 · Dec 31, 2025Inventory
3.09BCNYFY2025 · Dec 31, 2025Accounts Payable
1.70BCNYFY2025 · Dec 31, 2025Short-term Debt
998.11MCNYFY2025 · Dec 31, 2025Other Current Liabilities
323.01MCNYFY2025 · Dec 31, 2025Long-term Debt
430.89MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
37.92MCNYFY2025 · Dec 31, 2025Common Stock (Book)
715.09MCNYFY2025 · Dec 31, 2025Retained Earnings
1.77BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
5.57BCNY827.34M · vs all stocks (USD)
52-Week Low
7.38CNYUpdated Aug 19, 202652-Week High
13.69CNYUpdated Aug 19, 202652-Week Change
-2.84%vs all stocks
Beta
0.6320xvs all stocks
50-Day MA
8.31CNYUpdated Aug 19, 2026200-Day MA
9.63CNYUpdated Aug 19, 2026Avg 10-Day Volume
28.53MSharesUpdated Aug 19, 2026Avg 30-Day Volume
29.56MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.5400CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.34: grey zoneSignificant
Altman Z-Score: 1.34
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Revenue is $859.81M, above the global median of $520.53MNotable
Revenue (USD): 859,808,162.877Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Sumavision Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Changzhou NRB Corp.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Huayuan Auto Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhejiang Chunhui Intelligent Control Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shin Nippon Air Technologies Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sanyo Denki Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Nanjing Redsun Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Hebei Cangzhou Dahua Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Anhui Estone Materials Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Shenzhen Uniconn Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule